Gentao Liu

7.1k total citations · 2 hit papers
62 papers, 5.7k citations indexed

About

Gentao Liu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Gentao Liu has authored 62 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Molecular Biology and 21 papers in Immunology. Recurrent topics in Gentao Liu's work include Immunotherapy and Immune Responses (18 papers), Glioma Diagnosis and Treatment (10 papers) and Cancer Cells and Metastasis (8 papers). Gentao Liu is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Glioma Diagnosis and Treatment (10 papers) and Cancer Cells and Metastasis (8 papers). Gentao Liu collaborates with scholars based in United States, China and Canada. Gentao Liu's co-authors include Keith L. Black, John S. Yu, Xiangpeng Yuan, Christopher J. Wheeler, Hiushan Ng, Dwain K. Irvin, Zhaohui Zeng, Patrizia Tunici, Lizhi Lu and Ying Han and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Gentao Liu

60 papers receiving 5.6k citations

Hit Papers

Analysis of gene expression and chemoresistance of CD133+... 2004 2026 2011 2018 2006 2004 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
    2006 1.4k citations Gentao Liu, Xiangpeng Yuan et al. Molecular Cancer profile →
  2. Isolation of cancer stem cells from adult glioblastoma multiforme
    2004 636 citations Xiangpeng Yuan, James F. Curtin et al. Oncogene profile →

Peers

Gentao Liu
Yuri Kotliarov United States
Robert Soriano United States
Zhi Huang China
M. James You United States
Elizabeth W. Newcomb United States
Domenico Delia Italy
Alicia Pedraza United States
Jayne M. Stommel United States
Shi‐Cang Yu China
You‐Hong Cui China
Yuri Kotliarov United States
Gentao Liu
Citations per year, relative to Gentao Liu Gentao Liu (= 1×) peers Yuri Kotliarov

Countries citing papers authored by Gentao Liu

Since Specialization
Citations

This map shows the geographic impact of Gentao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gentao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gentao Liu more than expected).

Fields of papers citing papers by Gentao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gentao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gentao Liu. The network helps show where Gentao Liu may publish in the future.

Co-authorship network of co-authors of Gentao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Gentao Liu. A scholar is included among the top collaborators of Gentao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gentao Liu. Gentao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xi, X. Ai, Heyong Wang, et al.. (2018). A novel human IL-2 mutein with minimal systemic toxicity exerts greater antitumor efficacy than wild-type IL-2. Cell Death and Disease. 9(10). 989–989. 33 indexed citations
2.
3.
4.
Zhao, Mingchuan, Yishi Zhang, Huijun Zhang, et al.. (2014). Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma. Lung Cancer. 87(2). 98–106. 55 indexed citations
5.
Ren, Mingqiang, Mei Hong, Gentao Liu, et al.. (2013). Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1. Oncology Reports. 29(6). 2181–2190. 63 indexed citations
6.
Wang, Heyong, Huijun Zhang, Liang Tang, et al.. (2012). Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology. 303. 139–146. 136 indexed citations
7.
Xu, Qijin, Xiangpeng Yuan, Jinwei Hu, et al.. (2009). Chemokine CXC receptor 4–mediated glioma tumor tracking by bone marrow–derived neural progenitor/stem cells. Molecular Cancer Therapeutics. 8(9). 2746–2753. 17 indexed citations
8.
Liu, Gentao, et al.. (2008). Dendritic Cell Immunotherapy for Malignant Gliomas. Reviews on Recent Clinical Trials. 3(1). 10–21. 19 indexed citations
9.
Liu, Gentao, Xiangpeng Yuan, Zhaohui Zeng, et al.. (2006). Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Molecular Cancer. 5(1). 67–67. 1405 indexed citations breakdown →
10.
Zeng, Zhaohui, Xiangpeng Yuan, Gentao Liu, et al.. (2006). Manipulation of proliferation and differentiation of human bone marrow‐derived neural stem cells in vitro and in vivo. Journal of Neuroscience Research. 85(2). 310–320. 9 indexed citations
11.
Tunici, Patrizia, Dwain K. Irvin, Gentao Liu, et al.. (2006). Brain tumor stem cells: new targets for clinical treatments?. Neurosurgical FOCUS. 20(4). E27–E27. 18 indexed citations
12.
Yu, John S., et al.. (2005). Glioblastoma Cancer Stem Cells Exhibit Chemoresistance with Overexpression of Multidrug Resistance Gene BCRP-1. Neurosurgery. 57(2). 428–428. 2 indexed citations
13.
Yu, John S., et al.. (2005). Interleukin-23-expressing Bone Marrow-derived Neural Stem-like Cells Exhibit Antitumor Activity against Intracranial Glioma. Neurosurgery. 57(2). 411–411. 84 indexed citations
14.
Liu, Gentao, Hiushan Ng, Yasuharu Akasaki, et al.. (2004). Small interference RNA modulation of IL‐10 in human monocyte‐derived dendritic cells enhances the Th1 response. European Journal of Immunology. 34(6). 1680–1687. 56 indexed citations
15.
Yuan, Xiangpeng, James F. Curtin, Yizhi Xiong, et al.. (2004). Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 23(58). 9392–9400. 636 indexed citations breakdown →
16.
Ehtesham, Moneeb, Xiangpeng Yuan, Peter Kabos, et al.. (2004). Glioma Tropic Neural Stem Cells Consist of Astrocytic Precursors and Their Migratory Capacity Is Mediated by CXCR4. Neoplasia. 6(3). 287–293. 118 indexed citations
17.
Xie, Dong, Dong Yin, Hejing Wang, et al.. (2004). Levels of Expression of CYR61 and CTGF Are Prognostic for Tumor Progression and Survival of Individuals with Gliomas. Clinical Cancer Research. 10(6). 2072–2081. 160 indexed citations
18.
Wheeler, Christopher J., Keith L. Black, Gentao Liu, et al.. (2003). Thymic CD8+ T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality. The Journal of Immunology. 171(9). 4927–4933. 66 indexed citations
19.
Liu, Gentao, Huijun Guo, Ruihua Huang, Linyun Wang, & Claude L. Hughes. (2001). Ovarian Toxicity of Galactose to Egg-Laying Quails and the Preventive Effects of Taurine. Jiangsu nongye xuebao. 17(1). 44–48.
20.
Liu, Gentao, et al.. (1999). Development of a radioimmunoassay for insulin-like growth factor-1. Nanjing Nongye Daxue xuebao. 22(2). 63–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuri Kotliarov Breakdown of academic impact, for papers by Robert Soriano Breakdown of academic impact, for papers by Zhi Huang Breakdown of academic impact, for papers by M. James You Breakdown of academic impact, for papers by Elizabeth W. Newcomb Breakdown of academic impact, for papers by Domenico Delia Breakdown of academic impact, for papers by Alicia Pedraza Breakdown of academic impact, for papers by Jayne M. Stommel Breakdown of academic impact, for papers by Shi‐Cang Yu Breakdown of academic impact, for papers by You‐Hong Cui
Rankless by CCL
2026